本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Nuvectis Pharma, Inc.

8.99
-0.2300-2.49%
盘后8.990.00000.00%18:57 EDT
成交量:12.41万
成交额:111.57万
市值:2.10亿
市盈率:-7.97
高:9.43
开:9.19
低:8.81
收:9.22
数据加载中...
2022/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/01/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/01/18

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/30

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/30

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/30

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/11/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/26

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/11/04

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/02

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/10/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/06

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933